Navigation Links
2 federal public health grants awarded to Weill Cornell Medical College

NEW YORK (Jan. 16, 2008) -- Two major federal grants have been awarded to Public Health faculty at Weill Cornell Medical College in New York City.

Dr. Kenneth W. Griffin is the recipient of a three-year $1.6 million NIH grant from the National Institute on Drug Abuse (NIDA) for research into the long-term effects of a school-based drug-abuse prevention program previously delivered to urban minority youth attending New York City middle schools. The study will focus on a sample of approximately 3,500 young adults, ages 21 to 23, who participated in a randomized prevention trial during their early teens. In addition to testing the long-term effects of the prevention program on alcohol, tobacco and illicit drug use among the participants as young adults, the study will test whether the effects generalize to a variety of sexual risk behaviors.

Dr. Griffin is associate professor of public health in the Division of Prevention and Health Behavior, Department of Public Health, Weill Cornell Medical College.

Dr. Inmaculada de Melo-Martn is the recipient of a two-year $150,000 National Science Foundation Grant (NSF) for innovative research examining the ways in which the concept of human dignity is used in current debates about contentious biotechnologies such as embryonic stem cell research, human genetic enhancement and the creation of human-nonhuman chimeras. It will provide the first systematic assessment of what several influential scholars and recent national and international science policy documents mean when they say that these technologies threaten human dignity. Thus, the research can play a role in improving dialogue between the sciences and the humanities, and between the sciences and society.

Dr. de Melo-Martn is associate professor of public health in the Division of Medical Ethics, Department of Public Health, Weill Cornell Medical College.

"These awards represent important acknowledgments of the societal value of Dr. Griffin's and Dr. de Melo-Martn's work," says Dr. Alvin I. Mushlin, the Nanette Laitman Professor and Chairman of the Department of Public Health at Weill Cornell. "They are also examples of the diversity in public health research being conducted in the Department."


Contact: Andrew Klein
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College

Related biology news :

1. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
2. NOAA proposes federal regulations to protect black abalone
3. How the public perceives biotech
4. Anthony S. Fauci awarded Lasker Award for Public Service
5. Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study
6. BIO-key International Showcasing Innovative Public Safety Solutions at 2007 IACP Conference
7. Mandate for public access to NIH-funded research poised to become law
8. Market testing of dietary supplements and drugs underscores value of USPs public health programs
9. Asthma link to post-traumatic stress disorder, says Mailman School of Public Health study
10. Columbia researchers: Growth of CT scan use may lead to significant public health problem
11. Wireless Public Safety Solution From BIO-key(R) and DaProSystems Links Virginia Law Enforcement Agencies
Post Your Comments:
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon ... over 2,000 technical presentations offered in symposia, oral sessions, workshops, awards, and posters. ... a wide range of applications such as, but not limited to, biotechnology, biomedical, ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) holds ... organisation (CRO) market. The trend of outsourcing to ... margins but higher volume share for the region ... scale, however, margins in the CRO industry will ... Market ( ), finds that the ...
Breaking Biology Technology: